Risdiplam in Presymptomatic Spinal Muscular Atrophy
New England Journal of Medicine · 14.08.2025 · 393 (7) · 671-682
DOI: 10.1056/nejmoa2410120 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift New England Journal of Medicine, erschienen am 14.08.2025. Verfasst von Richard S Finkel und 22 weiteren Autor:innen. Beteiligte Einrichtung: Center for Experimental Neurotherapeutics, Department of Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN. Hauptthemen laut MEDLINE: Spinal Muscular Atrophies of Childhood, Survival of Motor Neuron 2 Protein, Neuromuscular Agents, RNA Splicing. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Experimental Neurotherapeutics, Department of Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN.
- MDUK (Muscular Dystrophy UK) Oxford Neuromuscular Centre and NIHR (National Institute for Health and Care Research) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
- Neuromuscular Reference Center, Department of Pediatrics, University Hospital Liège and University of Liège, Liège, Belgium.
- Russian Children Neuromuscular Center, Veltischev Clinical Pediatrics and Pediatric Surgery Research Institute of Pirogov Russian National Research Medical University, Moscow.
- Department of Neurology, Faculdade de Medicina, Universidade de São Paulo, São Paulo.
- Department of Developmental Neurology, Chair of Neurology, Medical University of Gdańsk, Gdańsk, Poland.
Zitieren
APA
Finkel, R. S., Servais, L., Vlodavets, D., Zanoteli, E., Mazurkiewicz-Bełdzińska, M., Jong, Y. J., Navas-Nazario, A., Al-Muhaizea, M., Araujo, A. P. Q. C., Nelson, L., Wang, Y., Jaber, B., Gorni, K., Kletzl, H., Palfreeman, L., Rabbia, M., Summers, D., Gaki, E., Wagner, K. R., …, & RAINBOWFISH Study Group (2025). Risdiplam in Presymptomatic Spinal Muscular Atrophy. New England Journal of Medicine, 393(7), 671-682. https://doi.org/10.1056/nejmoa2410120
Vancouver
Finkel RS, Servais L, Vlodavets D, Zanoteli E, Mazurkiewicz-Bełdzińska M, Jong YJ, et al. Risdiplam in Presymptomatic Spinal Muscular Atrophy. New England Journal of Medicine. 2025;393(7):671-682. doi:10.1056/nejmoa2410120
BibTeX
@article{Finkel2025,
author = {Finkel, Richard S and Servais, Laurent and Vlodavets, Dmitry and Zanoteli, Edmar and Mazurkiewicz-Bełdzińska, Maria and Jong, Yuh-Jyh and Navas-Nazario, Aledie and Al-Muhaizea, Mohammad and Araujo, Alexandra P Q C and Nelson, Leslie and Wang, Yi and Jaber, Birgit and Gorni, Ksenija and Kletzl, Heidemarie and Palfreeman, Laura and Rabbia, Michael and Summers, Dave and Gaki, Eleni and Wagner, Kathryn R and Fontoura, Paulo and Farrar, Michelle A and Bertini, Enrico and RAINBOWFISH Study Group, RAINBOWFISH Study Group},
title = {Risdiplam in Presymptomatic Spinal Muscular Atrophy},
journal = {New England Journal of Medicine},
year = {2025},
volume = {393},
number = {7},
pages = {671--682},
doi = {10.1056/nejmoa2410120}
}
EUVIMED